Enzo Biochem
Quarterly Financials
| Values in thousands | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 |
|---|---|---|---|---|
Revenue | $7,526 | $8,022 | $8,553 | $7,806 |
Gross Profit | 3,220 | 3,733 | 4,224 | 3,455 |
EBITDA | -2,049 | -1,014 | -1,157 | -1,722 |
EBIT | -2,447 | -1,351 | -1,424 | -1,992 |
Net Income | -13,381 | -3,020 | -3,061 | -6,616 |
Net Change In Cash | 7,526 | 8,022 | 8,553 | 7,806 |
Free Cash Flow | -1,208 | -3,005 | -8,963 | -13,628 |
Cash | 52,371 | 62,156 | 65,241 | 69,207 |
Basic Shares | 52,244 | 51,214 | 50,490 | 50,184 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
Revenue | $31,907 | $31,061 | $107,071 | $117,731 |
Gross Profit | 14,632 | 11,566 | 41,967 | 53,577 |
EBITDA | -8,348 | -12,118 | -10,958 | 12,531 |
EBIT | -9,620 | -14,800 | -13,785 | 9,878 |
Net Income | -26,078 | 20,288 | -22,578 | 3,425 |
Net Change In Cash | 31,907 | 31,061 | 107,071 | 117,731 |
Cost of Revenue | 8,392 | |||
Free Cash Flow | -26,804 | -39,736 | -20,062 | -4,049 |
Cash | 52,371 | 82,373 | 21,603 | 13,524 |
Basic Shares | 50,902 | 49,160 | 48,594 | 48,325 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-04-30 | -$0.05 |
2024-01-31 | -$0.06 |
2023-10-31 | -$0.13 |
2023-04-30 | -$0.30 |
